Psilera Inc
Next-generation neuroplastogen molecules for treating neurological disorders
- Sector
- Biotech
- Headquarters
- TAMPA, FL
- Founded
- 2021
- Latest Form D
- $2.5M, Aug 2021
- Total capital
- $2.5M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $2.5M
- 1 Form D · last Aug 2021
- 62 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 3
- 13 pending · first 2022
- Rank in peer group#339 of 1449
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 1st filing$2.5M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 1449 peers
Line = medianBiotech · Molecule
- Granted patents#339 · top 23%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Jacqueline Lee SalmExecutive OfficerNamed in SEC Form D filings
- Scott Lee RairighDirectorNamed in SEC Form D filings
What it has protected
USPTO · 3 granted of 16- Pending5-HT2A Receptor LigandsUSPTOApplication 19116549
- PendingCompositions of Matter and Pharmaceutical CompositionsUSPTOApplication 18939776
- PendingModified Indole CompoundsUSPTOApplication 18689983
Show all 16 patent records
- 5-HT2A Receptor LigandsDec 18, 2025 · Application 19116549Pending
- Compositions of Matter and Pharmaceutical CompositionsFeb 27, 2025 · Application 18939776Pending
- Modified Indole CompoundsJan 2, 2025 · Application 18689983Pending
- Novel Compositions Of Matter And Pharmaceutical CompositionsAug 6, 2024 · US 12,053,453Granted
- Novel Compositions Of Matter And Pharmaceutical CompositionsSep 19, 2023 · US 11,759,452Granted
- Novel Compositions Of Matter And Pharmaceutical CompositionsOct 25, 2022 · US 11,478,449Granted
- 5-HT2A Receptor LigandsApplication 63417732Pending
- N,n-dimethyltryptamine (dmt) Crystalline Products And Methods Of Making The SameApplication 63273673Pending
- Modified Indole CompoundsApplication 63273710Pending
- Formulations Containing Tryptamine Derivatives And Uses ThereofApplication 19482459Pending
- Novel Compositions Of Matter And Pharmaceutical CompositionsApplication PCTUS2021031215Pending
- Formulations Containing Tryptamine Derivatives And Uses ThereofApplication PCTUS2024030937Pending
- 5-HT2A Receptor LigandsApplication PCTUS2023077243Pending
- Formulations Containing Tryptamine Derivatives And Uses ThereofApplication 63504034Pending
- N,n-dimethyltryptamine (dmt) Crystalline Products And Methods Of Making The SameApplication PCTUS2022047520Pending
- Modified Indole CompoundsApplication PCTUS2022047552Pending
Related companies, and why
- Protillion Biosciences, lnc.Similar federal contract value in Biotech · null in contracts
- Myosana Therapeutics Inc.Similar federal contract value in Biotech · null in contracts
- Urica Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
- Valted Seq, Inc.Similar federal contract value in Biotech · null in contracts
- INSAMO INC.Similar federal contract value in Biotech · null in contracts
- Ancilia Biosciences, Inc.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .